Michael K. Haseman - Concepedia

Author

Michael K. Haseman

Also Known As

M Haseman, M K Haseman, M. K. HASEMAN, M. K. Haseman, M.K. Haseman, MICHAEL K. HASEMAN, Michael Haseman, Michael K. Haseman

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Sutter Medical Center Washington University Medical Center Imaging Center University of Iowa Stanford University

About

Michael K. Haseman is an author at Sutter Medical Center specializing in radiology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	240
2	Health Sciences	4	4	393
3	Engineering	3	3	418
4	Allergy	1	1	33
5	Biochemistry	1	1	18

Michael K. Haseman

Publications

Citations

H-Index

Page 1

	Year	Citations
Staging non—small cell lung cancer by whole-body positron emission tomographic imaging Peter E. Valk, Thomas R. Pounds, Donald M. Hopkins, The Annals of Thoracic Surgery Positron Emission TomographyEngineeringCell Lung CancerMedical ImagingWhole-body Positron Emission	1995	317
( <sup>111</sup> ) INDIUM-CAPROMAB PENDETIDE IN THE EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY Daniel Kahn, Richard D. Williams, Michael J. Manyak, The Journal of Urology	1998	172
Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy. Daniel Kahn, Richard D. Williams, Michael K. Haseman, Journal of Clinical Oncology	1998	151
Comparison of clinical staging algorithms and111Indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients Thomas J. Polascik, Michael J. Manyak, Michael K. Haseman, Cancer	1999	105
Monoclonal Antibody Imaging of Occult Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Michael K. Haseman, Nancy L. Reed, Seth A. Rosenthal Clinical Nuclear Medicine EngineeringOncologic ImagingDiagnosisMonoclonal Antibody ImagingElevated Prostate-specific Antigen	1996	83
Metabolizable 111in chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in mice Michael K. Haseman, David A. Goodwin, Claude F. Meares, European Journal of Nuclear Medicine and Molecular Imaging Lymphoid NeoplasiaCancer ImmunosurveillanceImmunologyPathologyAnti-idiotype Monoclonal Antibody	1986	53
Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse. David A. Goodwin, Claude F. Meares, Michael J. McCall, PubMed Immunocytochemical TechniqueLaboratory ImmunologyImmunologyAlpha Iak MoabImmunophenotyping	1985	33
Radioimmunodetection of occult carcinoembryonic antigen-producing cancer. Michael K. Haseman, Donald W. Brown, Christine A. Keeling, PubMed Tumoral PathologyCancer ImmunosurveillanceHealth SciencesMalignant DiseaseElevated Cea Levels	1992	30
The role of (111)In Capromab Pendetide (Prosta-ScintR) immunoscintigraphy in the management of prostate cancer. LM Freeman, Borys R. Krynyckyi, Yi Li, PubMed UrologySurgical OncologyOncologic ImagingGenitourinary CancerMedicine	2002	28
Gamma probe location of <sup>111</sup> indium‐labeled B72.3: An extension of immunoscintigraphy David N. Krag, Michael K. Haseman, Patrick V. Ford, Journal of Surgical Oncology	1992	24

Page 1